Candriam S.C.A. Insmed Inc Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

A detailed history of Candriam S.C.A. transactions in Insmed Inc stock. As of the latest transaction made, Candriam S.C.A. holds 476,494 shares of INSM stock, worth $34 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

476,494

Previous 555,934 14.29%

Holding current value

$34 Million

Previous $37.2 Million 6.61%

% of portfolio

0.2%

Previous 0.23%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$62.0 - $79.01 $4.93 Million - $6.28 Million	-79,440 Reduced 14.29%	476,494 $34.8 Million
Q2 2024 Aug 05, 2024	BUY	$22.0 - $69.71 $3.65 Million - $11.6 Million	165,734 Added 42.47%	555,934 $37.2 Million
Q1 2024 May 03, 2024	BUY	$25.72 - $29.94 $2.06 Million - $2.4 Million	80,000 Added 25.79%	390,200 $10.6 Million
Q4 2023 Feb 14, 2024	SELL	$23.42 - $31.74 $351,300 - $476,100	-15,000 Reduced 4.61%	310,200 $9.61 Million
Q3 2023 Nov 13, 2023	SELL	$19.86 - $26.93 $9.57 Million - $13 Million	-482,000 Reduced 59.71%	325,200 $8.21 Million
Q2 2023 Aug 08, 2023	SELL	$16.44 - $21.1 $3.12 Million - $4.01 Million	-189,892 Reduced 19.04%	807,200 $17 Million
Q1 2023 May 12, 2023	SELL	$16.26 - $21.73 $896,056 - $1.2 Million	-55,108 Reduced 5.24%	997,092 $17 Million
Q3 2022 Nov 10, 2022	SELL	$20.88 - $28.21 $17.3 Million - $23.4 Million	-830,248 Reduced 44.1%	1,052,200 $22.7 Million
Q2 2022 Aug 03, 2022	BUY	$17.07 - $25.71 $7.24 Million - $10.9 Million	423,974 Added 29.07%	1,882,448 $37.1 Million
Q1 2022 May 13, 2022	BUY	$20.42 - $28.13 $10.1 Million - $13.9 Million	492,719 Added 51.02%	1,458,474 $34.3 Million
Q4 2021 Feb 10, 2022	BUY	$25.89 - $33.45 $2.23 Million - $2.88 Million	86,208 Added 9.8%	965,755 $26.3 Million
Q3 2021 Nov 09, 2021	BUY	$22.46 - $29.47 $8.41 Million - $11 Million	374,306 Added 74.08%	879,547 $24.2 Million
Q2 2021 Jul 20, 2021	BUY	$24.17 - $36.01 $5.37 Million - $8.01 Million	222,340 Added 78.59%	505,241 $14.4 Million
Q4 2020 Jan 22, 2021	SELL	$31.45 - $40.54 $286,163 - $368,873	-9,099 Reduced 3.12%	282,901 $9.42 Million
Q2 2020 Jul 23, 2020	BUY	$14.11 - $29.42 $4.12 Million - $8.59 Million	292,000 New	292,000 $8.04 Million
Q1 2019 May 02, 2019	SELL	$13.91 - $31.15 $981,586 - $2.2 Million	-70,567 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$11.6 - $18.7 $1,740 - $2,805	-150 Reduced 0.21%	70,567 $926,000
Q3 2018 Nov 07, 2018	SELL	$18.95 - $28.08 $461,432 - $683,748	-24,350 Reduced 25.61%	70,717 $1.45 Million
Q2 2018 Aug 14, 2018	BUY	$20.0 - $29.72 $1.9 Million - $2.83 Million	95,067 New	95,067 $2.25 Million

Others Institutions Holding INSM

# of Institutions

462

Shares Held

181M

Call Options Held

2.07M

Put Options Held

2.28M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.65B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account